Benitec Biopharma
Stock Forecast, Prediction & Price Target
Benitec Biopharma Financial Estimates
Benitec Biopharma Revenue Estimates
Benitec Biopharma EBITDA Estimates
Benitec Biopharma Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 6/30/2022 | 6/30/2023 | 6/30/2024 | 6/30/2026 | 6/30/2027 | 6/30/2028 | |
Revenue
% change YoY
| $73K N/A | $75K 2.73% | $216K 188% | Avg: $28.03K Low: $28.03K High: $28.03K avg. -87.01% | Avg: $96.09M Low: $96.09M High: $96.09M avg. 342638.27% | Avg: $39.64M Low: $39.64M High: $39.64M avg. -58.74% | |
Net Income
% change YoY
| $-18.56M N/A | $-19.56M -5.38% | $-21.75M -11.19% | Avg: $-34.10M Low: $-6.44M High: $-6.44M avg. -56.81% | Avg: $-5.72M Low: $-5.72M High: $-5.72M avg. 83.20% | Avg: $597.63K Low: $597.63K High: $597.63K avg. 110.43% | |
EBITDA
% change YoY
| $-17.93M N/A | $-18.7M -4.27% | $-22.49M -20.26% | Avg: $-21.36K Low: $-21.36K High: $-21.36K avg. 99.90% | Avg: $-73.21M Low: $-73.21M High: $-73.21M avg. -342645.49% | Avg: $-30.20M Low: $-30.20M High: $-30.20M avg. 58.74% | |
EPS
% change YoY
| -$38.62 N/A | -$14.12 63.43% | -$5.36 62.03% | Avg: -$4.65 Low: -$4.65 High: -$4.65 avg. 13.20% | Avg: -$4.13 Low: -$4.13 High: -$4.13 avg. 11.13% | Avg: $0.43 Low: $0.43 High: $0.43 avg. 110.43% | |
Operating Expenses
% change YoY
| $17.91M N/A | $19.15M 6.90% | $22.38M 16.84% | Avg: $1.93M Low: $1.93M High: $1.93M avg. -91.36% | Avg: $6.62B Low: $6.62B High: $6.62B avg. 342638.28% | Avg: $2.73B Low: $2.73B High: $2.73B avg. -58.74% | |
FAQ
What is Benitec Biopharma stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 45.60% in 2026-2028.
We have gathered data from 1 analysts. Their low estimate is -6.44M, average is -34.10M and high is -6.44M.
What is Benitec Biopharma stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 114164.16% in 2026-2028.
We have gathered data from 1 analysts. Their low revenue estimate is $28.03K, average is $28.03K and high is $28.03K.
What is Benitec Biopharma stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 44.92% in 2026-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$4.65, average is -$4.65 and high is $-4.65.
What is the best performing analyst?
In the last twelve months analysts have been covering Benitec Biopharma stock. The most successful analyst is Mani Foroohar.